+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 2Years - 18Years
All Genders
ID07530640

Atorvastatin Treatment in Children Aged 2 to 18 with Acute Kawasaki Disease and Coronary Artery Abnormalities

Led by Children's Hospital of Fudan University · Updated on 2026-06-16

9

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the safety and effects of atorvastatin in Chinese children aged 2 to 18 with acute Kawasaki disease KD complicated by coronary artery abnormalities CAA. Kawasaki disease is an acute inflammation of blood vessels primarily affecting children, which can lead to coronary artery aneurysms and severe heart problems. Although intravenous immunoglobulin treatment has reduced CAA rates, some children still develop serious coronary artery issues. Statins, known for cholesterol lowering and anti-inflammatory effects in adults, are being studied for their potential to control inflammation and improve coronary artery health in children with KD. Participants will be divided into four groups three groups will receive atorvastatin at different dose levels 0.15 mgkgday, 0.25 mgkgday, and 0.4 mgkgday for 6 weeks along with conventional therapy, while the fourth group will receive conventional therapy alone. This dose-escalation study aims to determine the maximum tolerated dose by monitoring side effects and inflammatory markers. The treatment period is 6 weeks, during which atorvastatins impact on inflammation and coronary artery changes will be assessed. During the study, participants will undergo evaluations before treatment, and at 1, 2, and 6 weeks after starting atorvastatin. These assessments include blood tests for inflammation markers like C-reactive protein and interleukin-6, measurements of coronary artery size via echocardiography, and monitoring for any side effects related to statin use. The main outcome is to measure the incidence of statin-associated side effects, with additional outcomes tracking changes in inflammation and coronary artery status. The study is sponsored by Childrens Hospital of Fudan University and aims to complete by September 2027.

CONDITIONS

Brief Title

Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities

Research Team

C

Chen Chu, MD

F

Fang Liu, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here